These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15803191)

  • 21. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation.
    Hoang MP; Prieto VG; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Sep; 28(8):400-6. PubMed ID: 11493377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.
    Nybakken GE; Sargen M; Abraham R; Zhang PJ; Ming M; Xu X
    Am J Dermatopathol; 2013 Feb; 35(1):25-9. PubMed ID: 22668579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
    Busam KJ; Granter SR; Iversen K; Jungbluth AA
    Am J Dermatopathol; 2000 Jun; 22(3):237-41. PubMed ID: 10871066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraganglioma-like dermal melanocytic tumor: a case report with particular features.
    Cimpean AM; Ceauşu R; Raica M
    Int J Clin Exp Pathol; 2009 Nov; 3(2):222-5. PubMed ID: 20126591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
    Sexton M; Sexton CW
    Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions.
    Prieto VG; McNutt NS; Lugo J; Reed JA
    J Cutan Pathol; 1997 Mar; 24(3):145-50. PubMed ID: 9085149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
    Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
    J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmoplastic nevus: clinicopathologic keynotes.
    Ferrara G; Brasiello M; Annese P; Francione S; Giorgio CM; Moscarella E; Zalaudek I; Argenziano G
    Am J Dermatopathol; 2009 Oct; 31(7):718-22. PubMed ID: 19684509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and immunohistopathological study of conjunctival melanocytic lesions in pediatric and adolescent patients. A case series.
    Bogdănici CM; Costea CF; Dumitrescu GF; Sava A; Ciobanu Apostol DG; Scripcariu DV; Nicoară SD; Tănase DM; Andriescu EC; Cărăuleanu A; Danciu M; Sălăvăstru SC; Schmitzer S; Cucu AI; Niagu IA
    Rom J Morphol Embryol; 2021; 62(4):907-915. PubMed ID: 35673810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatofibroma-like granular cell tumor.
    Cheng SD; Usmani AS; DeYoung BR; Ly M; Pellegrini AE
    J Cutan Pathol; 2001 Jan; 28(1):49-52. PubMed ID: 11168752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.